Smart ring maker Oura, shareholders look to raise up to $2.2 billion in US IPO
Oura, a maker of smart rings, plans to raise up to $2.2 billion in a US IPO, selling 50 million shares at $40-$44 each. Eli Lilly and Dragoneer may invest $100M and $300M, respectively. The company will list on Nasdaq as 'OURA'.
How this was made
The 30-second read
Why it matters
The filing signals a major capital infusion and expands the public market's exposure to digital health wearables.
Market read
First‑time public offering of a fast‑growing health‑tech firm, likely to attract both retail and institutional interest.
What to watch
Regulatory scrutiny of health data privacy and competition from larger wearables brands.
Background
Oura's smart ring tracks health metrics; the company seeks to capitalize on growing consumer health monitoring trends.
Ticker impact
Oura filed to raise up to $2.2 billion in a US IPO, offering 50 million shares at $40‑44 each and will list on Nasdaq as OURA.
Expect near‑term price swing of ±5‑10% as market digests valuation and demand from anchor investors.
Large raise size, anchor interest from Eli Lilly and Dragoneer, and Nasdaq listing create strong buying pressure, but pricing range leaves upside/downside risk.
Market effects
Adds a high‑growth consumer‑health tech player to the wearables sector, potentially lifting peers.
Boosts US IPO pipeline confidence amid market volatility.
Highlights continued investor appetite for health‑monitoring devices worldwide.
Counterpoint
The IPO may be over‑priced; demand could wane if market volatility persists.
Key entities
- companyOura
Smart ring maker filing for US IPO.
- investorEli Lilly
Potential anchor investor committing up to $100 million.
- investorDragoneer
Potential anchor investor committing up to $300 million.
